Donald M. Lloyd-Jones, M.D., ScM
Affiliations: | Epidemiology | Northwestern University Feinberg School of Medicine, Chicago, IL, United States | |
| Cardiology | Northwestern University Feinberg School of Medicine, Chicago, IL, United States |
Area:
cardiovascular disease, risk prediction, epidemiology, aging, preventative medicineGoogle:
"Donald Lloyd-Jones"Bio:
Dr. Lloyd-Jones’ research interests lie in cardiovascular disease epidemiology, risk estimation, and prevention. A main focus of his research has been investigation of the lifetime risks for various cardiovascular diseases, and factors which modify those risks. Other areas of interest include CVD risk estimation using novel biomarkers, imaging of subclinical atherosclerosis, and the epidemiology of hypertension. His clinical and teaching interests lie in general cardiology, with a focus on prevention.
Children
Sign in to add trainee| Brittany Megan Bogle | grad student | 2010-2015 | Northwestern School of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kong N, Sakhuja S, Colantonio LD, et al. (2023) Atherosclerotic cardiovascular disease events among adults with high predicted risk without established risk factors. American Journal of Preventive Cardiology. 17: 100612 |
| Khan SS, Coresh J, Pencina MJ, et al. (2023) Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation |
| Khan SS, Matsushita K, Sang Y, et al. (2023) Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations. Circulation |
| Yu J, Yang X, Deng Y, et al. (2023) Incorporating longitudinal history of risk factors into atherosclerotic cardiovascular disease risk prediction using deep learning. Research Square |
| Shea JW, Jacobs DR, Howard AG, et al. (2023) Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study. The American Journal of Clinical Nutrition |
| Zhang Y, Dron JS, Bellows BK, et al. (2023) Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease. Circulation. 147: 1556-1559 |
| Domanski MJ, Wu CO, Tian X, et al. (2023) Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors. Journal of the American College of Cardiology. 81: 1151-1161 |
| Jacobs JA, Addo DK, Zheutlin AR, et al. (2023) Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. Jama Cardiology |
| Lloyd-Jones DM, Wilkins JT. (2023) Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease. Journal of the American College of Cardiology. 81: 633-635 |
| Navar AM, Fine LJ, Ambrosius WT, et al. (2022) Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop. American Journal of Preventive Cardiology. 12: 100430 |